ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

4.70
Delayed Data
As of Mar 04
 +0.36 / +8.29%
Today’s Change
0.65
Today|||52-Week Range
5.15
+111.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization0.001.3K----
 
 
 
Operating ExpensesGross Income0.00-1.3K----
 
 
General Expenses140.2K1.7M----
 
 
 
Research And Development17.7K314.2K----
 
 
 
Total Operating Expenses140.2K1.7M----
 
 
 
 
Non-Operating ExpensesOperating Income-140.2K-1.7M----
 
 
 
Extraordinary Charge0.00-3.6M----
 
 
Interest Expense On Debt328.0012.9K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-140.5K-5.3M----
 
 
 
Net Income-140.5K-5.3M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.0M12.8M----
 
 
 
Shares To Calculate EPS Diluted9.0M12.8M----
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.41----
 
 
 
EPS Diluted-$0.02-$0.41----
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account